Headache
CGRP monoclonal antibodies improve benefit of onabotulinumtoxinA in patients with migraine
Patients with migraine who took calcitonin gene-related peptide-targeted monoclonal antibody therapy in combination with onabotulinumtoxinA had fewer monthly headache days and less migraine-related disability, according to researchers.
Survey: Telemedicine became 'essential tool' for headache care during COVID-19 pandemic
Telemedicine enabled headache care for “many patients” during the COVID-19 pandemic, with high rates of patient satisfaction, according to findings from a survey with more than 1,000 respondents.
Caffeinated coffee shows no impact on headache frequency during hemodialysis
Patients who consumed caffeinated coffee in the middle of hemodialysis sessions were not less likely to develop a headache than those who were given decaffeinated coffee, according to research conducted in Lebanon.
Most common neurologic symptoms in COVID-19 ‘long-haulers’ include ‘brain fog,’ headache
Non-hospitalized ‘long hauler’ patients with COVID-19 experienced “prominent and persistent” neurological symptoms, including brain fog and fatigue, according to results published in Annals of Clinical and Translational Neurology.
Combination treatment improves pain scores for post-traumatic headache in ED
Metoclopramide plus diphenhydramine resulted in greater improvement in pain scores compared with placebo for patients with acute post-traumatic headache in the ED, according to findings from a parallel group study published in Neurology.
Anosmia, myalgia, headache most common neurological symptoms of COVID-19
Neurological symptoms were among the most common clinical manifestations of COVID-19, with anosmia, myalgia and headache being the most frequently reported, data show.
Cannabis use affects rate of medication overuse headache in patients with migraine
Cannabis use ”significantly contributes” to the prevalence of medication overuse headache among patients with chronic migraine, according to study results scheduled for presentation at the American Academy of Neurology Annual Meeting.
Atypical presentation should not limit diagnosis of spontaneous intracranial hypotension
The absence of orthostatic headache should not exclude a diagnosis of spontaneous intracranial hypotension, according to findings published in JAMA Neurology.
Prazosin shows promise in treating post-traumatic headache
Prazosin, approved in the 1970s to control hypertension and used off-label to eliminate PTSD-related nightmares, was recently shown to prevent post-traumatic headaches in veterans in a small randomized controlled trial.
Medical marijuana often replaces other headache medications, small study shows
Most patients in a small cohort used medical marijuana in lieu of other abortive medications to alleviate migraine pain, according to recent findings.